SyntekaBio (226330) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, SyntekaBio (226330) reported revenue of 3.4 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
20253.4 billion KRW-10.8 billion KRW-17.4 billion KRW[source]
2024121 million KRW-14.3 billion KRW-7.2 billion KRW[source]
2023123 million KRW-12.3 billion KRW-11.4 billion KRW[source]
2022244 million KRW-11.8 billion KRW-4.5 billion KRW[source]
2021317 million KRW-8.9 billion KRW-14.8 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202546.3 billion KRW14.7 billion KRW31.5 billion KRW[source]
202443.7 billion KRW18.7 billion KRW24.9 billion KRW[source]
202354.9 billion KRW21.5 billion KRW33.3 billion KRW[source]
202256.5 billion KRW24.0 billion KRW32.5 billion KRW[source]
202167.7 billion KRW40.0 billion KRW27.6 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice